References
- Hajdu R, Thompson R, Sundelof JG, Pelak BA, Bouffard FA, Dropinski JF, . Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872). Antimicrob Agents Chemother. 1997;41(11):2339–44.
- Suzuki S, Terakawa M, Yokobayashi F, Fujiwara F, Hata T. Pharmacokinetics of FK463, a novel water-soluble echinocandin-like lipopeptide, in animals. Proceedings of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1998 Sep 24–27; San Diego, CA, USA. Abstr. F-144: 269.
- Wise R. The relevance of pharmacokinetics to in-vitro models: protein binding-does it matter? J Antimicrob Chemother. 1985;15 Suppl A:77–83.
- Ernst EJ, Roling EE, Petzold CR, Keele DJ, Klepser ME. In vitro activity of micafungin (FK-463) against Candida spp.: microdilution, time-kill, and postantifungal-effect studies. Antimicrob Agents Chemother. 2002;46(12):3846–53.
- Bartizal K, Gill CJ, Abruzzo GK, Flattery AM, Kong L, Scott PM, . In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872). Antimicrob Agents Chemother. 1997;41(11):2326–32.
- Odabasi Z, Paetznick V, Rex JH, Ostrosky-Zeichner L. Effects of serum on in vitro susceptibility testing of echinocandins. Antimicrob Agents Chemother. 2007;51:4214–6.
- Paderu P, Garcia-Effron G, Balashov S, Delmas G, Park S, Perlin DS. Serum differentially alters the antifungal properties of echinocandin drugs. Antimicrob Agents Chemother. 2007;51(6):2253–6.
- Arendrup MC, Rodriguez-Tudela JL, Park S, Garcia-Effron G, Delmas G, Cuenca-Estrella M, . Echinocandin susceptibility testing of Candida spp. using EUCAST EDef 7.1 and CLSI M27-A3 standard procedures: analysis of the influence of bovine serum albumin supplementation, storage time, and drug lots. Antimicrob Agents Chemother. 2011;55(4):1580–7.
- Garcia-Effron G, Park S, Perlin D. Improved detection of Candida sp. fks hot spot mutants by using the method of the CLSI M27-A3 document with the addition of bovine serum albumin. Antimicrob Agents Chemother. 2011;55(5):2245–55.
- Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeast. Approved standard M27-A3, 3rd edn. Clinical and Laboratory Standards Institute, Wayne, PA, USA, 2008.
- Pfaller MA, Diekema DJ, Andes D, Arendrup MC, Brown SD, Lockhart SR, . Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria. Drug Resist Up. 2011;14(3):164–76.